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Abstract	  
The	  genetic	  control	  of	  puberty	  remains	  an	  important	  but	  mostly	  unanswered	  
question.	  Late	  pubertal	  timing	  affects	  over	  2%	  of	  adolescents	  and	  is	  associated	  
with	  adverse	  health	  outcomes	  including	  short	  stature,	  reduced	  bone	  mineral	  
density	  and	  compromised	  psychosocial	  health.	  Self-­‐limited	  delayed	  puberty	  (DP)	  
is	  a	  highly	  heritable	  trait,	  which	  often	  segregates	  in	  an	  autosomal	  dominant	  
pattern;	  however,	  its	  neuroendocrine	  pathophysiology	  and	  genetic	  regulation	  
remain	  unclear.	  Some	  insights	  into	  the	  genetic	  mutations	  that	  lead	  to	  familial	  DP	  
have	  come	  from	  sequencing	  genes	  known	  to	  cause	  GnRH	  deficiency,	  most	  
recently	  via	  next	  generation	  sequencing,	  and	  others	  from	  large-­‐scale	  genome	  
wide	  association	  studies	  in	  the	  general	  population.	  Investigation	  of	  the	  genetic	  
control	  of	  DP	  is	  complicated	  by	  the	  fact	  that	  this	  trait	  is	  not	  rare	  and	  that	  the	  
phenotype	  is	  likely	  to	  represent	  a	  final	  common	  pathway,	  with	  a	  variety	  of	  
different	  pathogenic	  mechanisms	  affecting	  the	  release	  of	  the	  puberty	  ‘brake’.	  
These	  include	  abnormalities	  of	  GnRH	  neuronal	  development	  and	  function,	  GnRH	  
receptor	  and	  LH/FSH	  abnormalities,	  metabolic	  and	  energy	  homeostasis	  
derangements	  and	  transcriptional	  regulation	  of	  the	  HPG	  axis.	  Thus,	  genetic	  
control	  of	  pubertal	  timing	  can	  range	  from	  early	  fetal	  life	  via	  development	  of	  the	  
GnRH	  network,	  to	  those	  factors	  directly	  influencing	  the	  puberty	  brake	  during	  
mid-­‐childhood.	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Introduction	  
Puberty	  is	  the	  maturational	  process	  of	  the	  reproductive	  endocrine	  system	  that	  
results	  in	  achievement	  of	  adult	  height	  and	  body	  proportion,	  in	  addition	  to	  
development	  of	  the	  genital	  organs	  and	  the	  capacity	  to	  reproduce.	  The	  onset	  of	  
puberty	  is	  driven	  by	  an	  increase	  in	  the	  pulsatile	  release	  of	  gonadotropin-­‐
releasing	  hormone	  (GnRH)	  from	  the	  hypothalamus.	  This	  activation	  results	  in	  
increased	  luteinizing	  hormone	  (LH)	  and	  follicular-­‐stimulating	  hormone	  
(FSH)	  release	  from	  the	  anterior	  pituitary,	  which	  act	  on	  the	  gonads	  to	  stimulate	  
their	  development,	  gametogenesis	  and	  sex	  steroid	  production.	  
The	  development	  of	  the	  hypothalamic-­‐pituitary-­‐gonadal	  (HPG)	  axis	  is	  
exceptional	  in	  that	  GnRH	  neurons	  develop	  in	  metazoan	  embryos	  outside	  of	  the	  
central	  nervous	  system.	  Immature	  GnRH	  precursor	  neurons	  are	  first	  detectable	  
in	  the	  olfactory	  placode	  in	  the	  nose	  from	  an	  early	  embryological	  stage,	  and	  then	  
begin	  a	  complex	  journey	  towards	  the	  hypothalamus	  [1].	  
The	  axis	  is	  active	  in	  fetal	  and	  in	  early	  infant	  life,	  the	  so-­‐called	  ‘mini-­‐puberty’,	  and	  
then	  becomes	  dormant	  between	  the	  age	  of	  one	  and	  8-­‐9	  years	  [2].	  Development	  of	  
the	  clinical	  features	  of	  puberty	  is	  initiated	  by	  the	  reactivation	  of	  the	  HPG	  axis	  
after	  this	  relative	  quiescence	  during	  childhood.	  What	  drives	  this	  suppression	  of	  
the	  axis	  during	  childhood,	  and	  what	  controls	  the	  release	  of	  this	  ‘brake’	  and	  the	  
timing	  at	  which	  this	  occurs,	  is	  little	  understood.	  
Despite	  the	  demonstrated	  importance	  of	  environmental	  factors	  such	  as	  body	  
mass,	  psychosocial	  stressors	  and	  endocrine	  disrupting	  chemicals	  (EDCs)	  [3],	  
genetic	  influence	  on	  the	  timing	  of	  puberty	  is	  clearly	  fundamental.	  Whilst	  the	  
timing	  of	  pubertal	  onset	  varies	  within	  and	  between	  different	  populations,	  it	  is	  a	  
highly	  heritable	  trait.	  	  The	  timing	  of	  sexual	  maturation	  is	  highly	  correlated	  within	  
families	  and	  in	  twin	  studies,	  suggesting	  strong	  genetic	  determinants	  [4].	  
Previous	  epidemiological	  studies	  and	  genetic	  approaches	  estimate	  that	  60-­‐80%	  
of	  the	  variation	  in	  pubertal	  onset	  is	  under	  genetic	  regulation	  [5,	  6].	  However,	  
despite	  this	  strong	  heritability,	  little	  is	  known	  about	  the	  genetic	  control	  of	  human	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Investigating	  the	  Inheritance	  of	  Delayed	  Puberty	  
Self-­‐limited	  delayed	  puberty	  (DP),	  also	  known	  as	  constitutional	  delay	  of	  growth	  
and	  puberty	  (CDGP),	  represents	  the	  extreme	  end	  of	  normal	  pubertal	  timing,	  and	  
is	  defined	  as	  the	  absence	  of	  testicular	  enlargement	  in	  boys	  or	  breast	  
development	  in	  girls	  at	  an	  age	  that	  is	  2	  to	  2.5	  standard	  deviations	  (SD)	  later	  than	  
the	  population	  mean	  [7].	  In	  addition,	  self-­‐limited	  DP	  may	  also	  encompass	  older	  
children	  with	  delayed	  pubertal	  progression,	  a	  diagnosis	  that	  is	  aided	  by	  the	  use	  
of	  puberty	  normograms	  [8].	  Self-­‐limited	  DP	  is	  associated	  with	  adverse	  health	  
outcomes	  including	  short	  stature,	  reduced	  bone	  mineral	  density	  and	  
compromised	  psychosocial	  health	  [9].	  
Self-­‐limited	  DP	  represents	  the	  commonest	  cause	  of	  DP	  in	  both	  sexes.	  Up	  to	  63%	  
of	  boys	  with	  pubertal	  delay	  have	  self-­‐limited	  DP	  [10].	  	  Self	  limited	  DP	  segregates	  
within	  families	  with	  complex	  patterns	  of	  inheritance	  including	  autosomal	  
dominant,	  autosomal	  recessive,	  bilineal	  and	  X-­‐linked	  [11],	  although	  sporadic	  
cases	  are	  also	  observed	  (Figure	  1).	  The	  majority	  of	  families	  display	  an	  autosomal	  
dominant	  pattern	  of	  inheritance	  (with	  or	  without	  complete	  penetrance)	  [4,	  11].	  	  
50	  to	  75%	  of	  subjects	  with	  self-­‐limited	  DP	  have	  a	  family	  history	  of	  delayed	  
pubertal	  onset	  [11].	  	  
Analysis	  of	  self-­‐limited	  DP	  families	  is	  complicated	  by	  the	  fact	  that	  this	  phenotype	  
represents	  the	  tail	  of	  a	  normally	  distributed	  trait	  within	  the	  population,	  so	  it	  is	  
expected	  that	  variants	  that	  govern	  the	  inheritance	  of	  this	  condition	  will	  also	  be	  
present	  in	  the	  general	  population	  at	  a	  low	  level.	  Thus,	  the	  absence	  of	  these	  
variants	  in	  population	  databases	  cannot	  be	  used	  as	  an	  exclusion	  criterion.	  
Instead,	  a	  comparison	  of	  prevalence	  of	  such	  variants	  must	  be	  made	  to	  identify	  
those	  that	  are	  enriched	  in	  patients	  compared	  to	  the	  general	  population.	  In	  the	  
majority	  of	  patients	  with	  DP	  the	  neuroendocrine	  pathophysiology	  and	  its	  genetic	  
regulation	  remain	  unclear.	  Linkage	  analysis	  and	  targeted	  sequencing	  strategies	  
appear	  to	  have	  been	  superseded	  by	  whole	  exome	  and	  genome	  sequencing	  
strategies	  to	  identify	  novel	  candidate	  genes.	  
	  
Evidence	  from	  population	  studies	  
Attempts	  to	  identify	  key	  genetic	  regulators	  of	  the	  timing	  of	  puberty	  in	  humans	  
have	  led	  to	  several	  large	  genome	  wide	  association	  studies	  (GWAS)	  of	  age-­‐at-­‐
	   4	  
menarche,	  examining	  pubertal	  timing	  in	  healthy	  women	  [12-­‐14].	  These	  studies	  
demonstrate	  genetic	  heterogeneity	  in	  pubertal	  timing,	  with	  the	  observation	  that	  
the	  genetic	  architecture	  of	  the	  timing	  of	  puberty	  in	  healthy	  subjects	  is	  likely	  to	  
involve	  at	  least	  hundreds	  of	  common	  variants.	  The	  first	  of	  many	  loci	  associated	  
with	  age	  of	  menarche	  was	  the	  gene	  LIN28B	  [15].	  LIN28B	  is	  a	  human	  ortholog	  of	  
the	  gene	  that	  controls,	  through	  microRNAs,	  developmental	  timing	  in	  the	  
Caenorhabditis	  elegans.	  However,	  mutations	  in	  LIN28B	  have	  not	  to	  date	  been	  
identified	  in	  human	  patients	  with	  DP	  [16]	  or	  precocious	  puberty	  [17].	  	  
The	  most	  recent	  study	  of	  this	  type	  comprises	  1000	  Genomes	  Project-­‐imputed	  
genotype	  data	  in	  up	  to	  ∼370,000	  women,	  and	  identifies	  389	  independent	  signals	  
(P	  <	  5	  ×	  10-­‐8)	  for	  age	  at	  menarche	  [18].	  Per-­‐allele	  effect	  sizes	  ranged	  from	  1	  week	  
to	  five	  months.	  These	  signals	  explain	  ∼7.4%	  of	  the	  population	  variance	  in	  age	  at	  
menarche,	  corresponding	  to	  ∼25%	  of	  the	  estimated	  heritability.	  Many	  of	  these	  
signals	  have	  concordant	  effects	  on	  the	  age	  at	  voice	  breaking,	  a	  corresponding	  
milestone	  in	  males.	  However,	  in	  women	  the	  signals	  identified	  had	  stronger	  
effects	  on	  early	  than	  on	  late	  age	  of	  menarche,	  but	  in	  contrast	  had	  larger	  effect	  
estimates	  for	  relatively	  late	  than	  relatively	  early	  voice	  breaking	  in	  males	  [18].	  	  
Around	  250	  genes	  were	  identified	  via	  coding	  variation	  or	  associated	  expression,	  
particularly	  those	  expressed	  in	  neural	  tissues.	  Importantly,	  genes	  already	  
implicated	  in	  rare	  disorders	  of	  puberty	  were	  identified,	  including	  LEPR,	  GNRH1,	  
KISS1,	  TACR3.	  Two	  imprinted	  genes	  were	  also	  reported:	  MKRN3,	  paternally-­‐
inherited	  mutations	  in	  which	  have	  been	  identified	  as	  causal	  in	  pedigrees	  of	  
central	  precocious	  puberty	  (CPP)	  [19];	  and	  DLK1	  [20].	  MKRN3	  is	  the	  third,	  and	  to	  
date	  the	  most	  frequently	  mutated,	  gene	  in	  pedigrees	  with	  CPP	  [19],	  the	  others	  
being	  KISS1	  [21]	  and	  its	  receptor	  GPR54	  [22]	  which	  have	  been	  reported	  only	  
rarely.	  MKRN3	  is	  thought	  to	  contribute	  to	  the	  puberty	  ‘brake’	  restraining	  the	  HPG	  
axis	  via	  inhibition	  of	  GnRH	  release.	  Very	  recently	  a	  complex	  defect	  in	  DLK1	  has	  
been	  identified	  in	  one	  pedigree	  with	  CPP	  [20].	  However,	  neither	  MKRN3	  nor	  
DLK1	  mutations	  have	  been	  implicated	  in	  the	  pathogenesis	  of	  DP	  (Figure	  2).	  
	  
Genetics	  of	  GnRH	  deficiency	  or	  signalling	  
At	  the	  extreme	  end	  of	  the	  spectrum	  of	  DP	  are	  conditions	  of	  GnRH	  deficiency	  
including	  hypogonadotropic	  hypogonadism	  (HH),	  with	  complete	  failure	  to	  enter	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puberty.	  The	  condition	  may	  be	  due	  to	  failure	  of	  development	  of	  GnRH	  neurons,	  
lack	  of	  activation	  of	  GnRH	  secretion	  or	  disrupted	  GnRH	  signaling.	  Because	  of	  
different	  causes	  and	  incomplete	  penetrance,	  there	  is	  a	  wide	  spectrum	  of	  
phenotypes,	  ranging	  from	  complete	  HH	  with	  lack	  of	  pubertal	  development	  to	  a	  
partial	  hypogonadism	  with	  an	  arrest	  of	  pubertal	  development,	  and	  even	  
reversible	  HH	  in	  some	  patients	  post	  treatment	  [23,	  24].	  Despite	  recent	  advances,	  
with	  over	  twenty	  genes	  linked	  to	  this	  disorder	  identified,	  the	  pathophysiological	  
basis	  of	  HH	  in	  approximately	  50%	  of	  individuals	  remains	  unclear	  [2].	  In	  view	  of	  
the	  possible	  overlap	  between	  the	  pathophysiology	  of	  DP	  and	  conditions	  of	  GnRH	  
deficiency,	  a	  few	  studies	  have	  examined	  the	  contribution	  of	  mutations	  in	  HH	  
genes	  to	  the	  phenotype	  of	  self-­‐limited	  DP.	  
Loss-­‐of-­‐function	  mutations	  within	  the	  GnRH	  receptor	  are	  the	  most	  frequent	  
cause	  of	  autosomal	  recessive	  IHH,	  accounting	  for	  16%	  to	  40%	  of	  patients.	  
Mutations	  have	  been	  found	  within	  the	  extracellular,	  transmembrane	  and	  
intracellular	  domains	  of	  the	  receptor	  leading	  to	  impaired	  GnRH	  action	  [25].	  A	  
homozygous	  partial	  loss-­‐of-­‐function	  mutation	  in	  GNRHR	  was	  found	  in	  two	  
brothers,	  one	  with	  self-­‐limited	  DP	  and	  one	  with	  idiopathic	  HH	  [26],	  and	  a	  further	  
heterozygous	  mutation	  found	  in	  one	  male	  with	  self-­‐limited	  DP	  [27].	  A	  small	  
cohort	  of	  31	  patients	  was	  analysed	  for	  mutations	  in	  GHSR	  and	  5	  patients	  were	  
found	  to	  have	  point	  mutations	  in	  this	  gene	  [28].	  Additionally,	  mutations	  in	  
HS6ST1,	  FGFR1	  and	  newly	  in	  KLB	  have	  been	  found	  in	  a	  small	  number	  of	  kindreds	  
of	  HH	  patients	  and	  their	  relatives	  with	  DP	  [29-­‐31].	  Recently,	  variants	  in	  several	  
HH	  genes	  including	  GNRHR,	  TAC3,	  TACR3,	  IL17RD	  and	  SEMA3A	  have	  been	  
identified	  by	  whole	  exome	  sequencing	  in	  some	  cases	  of	  DP,	  including	  self-­‐limited	  
DP	  [32].	  However,	  these	  variants	  have	  not	  been	  tested	  in	  vitro	  or	  in	  vivo	  for	  
pathogenicity	  and	  thus	  may	  be	  an	  over-­‐estimation.	  However,	  the	  current	  picture	  
indicates	  that	  the	  genetic	  background	  of	  HH	  and	  DP	  may	  be	  largely	  different,	  or	  
shared	  by	  as	  yet	  undiscovered	  genes	  [27].	  
Genetic	  defects	  affecting	  the	  development	  of	  the	  anterior	  pituitary	  may	  also	  
cause	  GnRH	  deficiency.	  The	  pituitary	  transcription	  factors	  LHX3,	  SOX2	  and	  
HESX1	  are	  vital	  for	  early	  patterning	  of	  the	  forebrain	  and	  pituitary,	  and	  mutations	  
in	  these	  developmental	  genes	  result	  in	  syndromic	  hypopituitarism	  with	  
gonadotropin	  deficiency	  in	  humans	  [33].	  PROP1	  is	  important	  for	  the	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development	  of	  gonadotropin-­‐secreting	  cells	  and	  mutations	  in	  this	  gene	  are	  the	  
most	  common	  cause	  of	  combined	  pituitary	  hormone	  deficiency	  in	  humans	  [34].	  
Patients	  with	  PROP1	  mutations	  have	  variable	  GnRH	  deficiency	  ranging	  from	  DP	  
to	  congenital	  HH	  [33].	  Mutations	  in	  DAX1	  cause	  X-­‐linked	  adrenal	  hypoplasia	  
congenita	  with	  associated	  HH,	  but	  have	  not	  been	  found	  in	  isolated	  DP	  [35].	  	  
GnRH	  deficiency	  may	  also	  be	  associated	  with	  other	  conditions,	  particularly	  with	  
neurological	  phenotypes.	  Mutations	  in	  POLR3A/B	  result	  in	  the	  4H	  syndrome	  
(Hypomyelination,	  Hypodontia	  and	  Hypogonadotropic	  Hypogonadism)	  [36]	  
whilst	  those	  in	  RNF216,	  OTUD4	  and	  PNPLA6	  produce	  the	  phenotypic	  
combination	  of	  HH	  and	  ataxia	  (also	  know	  as	  Gordon-­‐Holmes	  syndrome)	  [37,	  38].	  
DMXL2	  mutations	  are	  associated	  with	  congenital	  HH,	  other	  endocrine	  
deficiencies	  and	  polyneuropathies	  [39].	  Dysregulation	  of	  the	  RAB3	  cycle,	  such	  as	  
with	  mutations	  in	  RAB3GAP1,	  lead	  to	  Warburg	  Micro	  syndrome	  with	  ocular,	  
neurodevelopmental	  and	  central	  reproductive	  defects	  [40,	  41].	  
Downstream	  mutations	  in	  the	  GnRH	  signaling	  pathway	  can	  also	  present	  with	  DP.	  
LH	  and	  FSH	  are	  glycoprotein	  hormones	  encoded	  by	  a	  common	  α-­‐subunit	  gene	  
and	  a	  specific	  β-­‐subunit	  gene.	  Mutations	  of	  the	  β-­‐subunits	  genes	  of	  LH	  or	  FSH	  
are	  extremely	  rare	  causes	  of	  pubertal	  abnormalities	  [42].	  Males	  with	  inactivating	  
mutations	  of	  the	  LHB	  have	  absent	  pubertal	  development	  with	  Leydig	  cell	  
hypoplasia	  leading	  to	  T	  deficiency	  and	  azoospermia.	  Females	  with	  inactivating	  
mutations	  of	  LHB	  present	  with	  onset	  of	  normal	  puberty,	  but	  with	  normal	  or	  late	  
menarche	  followed	  by	  infertility	  due	  to	  lack	  of	  ovulation	  [42].	  Individuals	  with	  
inactivating	  FSHB	  mutations	  present	  with	  incomplete	  pubertal	  development	  and	  
azoospermia	  in	  males	  and	  primary	  amenorrhea	  in	  females	  [43].	  
	  
Upstream	  regulation	  of	  the	  HPG	  axis	  
Kisspeptin,	  an	  excitatory	  neuropeptide,	  was	  identified	  as	  a	  permissive	  factor	  in	  
puberty	  onset	  by	  the	  discovery	  of	  patients	  with	  GnRH	  deficiency	  with	  loss-­‐of-­‐
function	  mutations	  in	  the	  KISS1	  receptor,	  KISS1R	  (previously	  known	  as	  GPR54)	  
[44,	  45].	  Mice	  with	  knockout	  of	  Kiss1r	  were	  simultaneously	  discovered	  to	  be	  
infertile	  despite	  anatomically	  normal	  GnRH	  neurons	  and	  normal	  hypothalamic	  
GnRH	  levels	  [45],	  with	  a	  phenotype	  consistent	  with	  normosmic	  GnRH	  deficiency.	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However,	  to	  date,	  only	  very	  rarely	  have	  human	  mutations	  in	  KISS1	  been	  found	  in	  
patients	  with	  delayed	  or	  absent	  puberty	  [46].	  
The	  excitatory	  neuropeptide,	  neurokinin	  b,	  also	  plays	  a	  role	  in	  the	  upstream	  
control	  of	  GnRH	  secretion.	  Identification	  of	  this	  pathway	  was	  also	  via	  discovery	  
of	  loss-­‐of-­‐function	  mutations	  in	  TAC3,	  encoding	  neurokinin	  b,	  and	  its	  receptor	  
TACR3,	  in	  patients	  with	  normosmic	  GnRH	  deficiency	  and	  pubertal	  failure	  [47].	  
Kisspeptin,	  neurokinin	  b	  and	  dynorphin	  are	  coexpressed	  in	  KNDy	  neurons	  of	  the	  
arcuate	  nucleus	  of	  the	  hypothalamus	  [48],	  which	  project	  to	  and	  directly	  interact	  
with	  GnRH	  neurons.	  Their	  expression	  is	  downregulated	  by	  oestrogen	  and	  
testosterone	  as	  part	  of	  the	  negative	  feedback	  regulation	  of	  gonadotropin	  
secretion	  [49,	  50].	  However,	  administration	  of	  neurokinin	  b	  agonists	  failed	  to	  
stimulate	  GnRH	  release	  in	  rodents,	  and	  Tacr3	  knockout	  mice	  have	  grossly	  
normal	  fertility	  [51,	  52].	  Of	  50	  self-­‐limited	  DP	  patients	  investigated	  for	  mutations	  
in	  TAC3	  and	  TAC3R,	  only	  one	  mutation	  in	  a	  single	  patient	  was	  found	  in	  the	  latter	  
gene	  [53].	  
The	  inhibitory	  role	  of	  GABAergic	  neurotransmission	  has	  been	  clearly	  shown	  in	  
primates	  [54]	  but	  is	  more	  ambiguous	  in	  rodents.	  Opioid	  peptides	  provide	  
additional	  inhibitory	  input	  but	  this	  appears	  to	  be	  less	  critical	  than	  the	  GABAergic	  
signals	  in	  restraining	  the	  initiation	  of	  puberty	  [55].	  Additionally,	  RFamide-­‐related	  
peptide	  gene	  (RFRP),	  the	  mammalian	  ortholog	  of	  the	  avian	  peptide	  
gonadotrophin-­‐inhibiting	  hormone	  (GnIH),	  has	  been	  identified	  as	  a	  further	  
inhibitory	  regulator	  of	  GnRH	  neuronal	  activity	  in	  mice	  [56].	  Glial	  inputs	  appear	  
to	  be	  predominantly	  facilitatory	  during	  puberty	  and	  consist	  of	  growth	  factors	  
and	  small	  diffusible	  molecules,	  including	  TGFβ1,	  IGF-­‐1	  and	  neuregulins,	  that	  
directly	  or	  indirectly	  stimulate	  GnRH	  secretion	  [57].	  
Upstream	  regulation	  of	  GnRH	  transcription	  is	  less	  well	  established.	  Candidate	  
transcriptional	  regulators	  identified	  from	  a	  systems	  biology	  approach	  and	  
animal	  models	  include	  Oct-­‐2,	  TTF-­‐1	  and	  EAP1	  [58].	  Oct-­‐2	  mRNA	  is	  upregulated	  in	  
the	  hypothalamus	  in	  juvenile	  rodents,	  blockage	  of	  Oct-­‐2	  synthesis	  delays	  age	  at	  
first	  ovulation	  whilst	  activation	  of	  Oct-­‐2	  expression	  (e.g.	  hamartomas)	  induces	  
precocious	  puberty	  [59].	  TTF-­‐1	  (thyroid	  transcription	  factor-­‐1)	  enhances	  GnRH	  
expression,	  with	  increased	  expression	  in	  pubertal	  rhesus	  monkeys	  [60].	  EAP1	  
mRNA	  levels	  also	  increase	  in	  primate	  and	  rodent	  hypothalamus	  during	  puberty.	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EAP1	  transactivates	  the	  GnRH	  promoter,	  and	  EAP1	  knockdown	  with	  siRNA	  
caused	  DP	  and	  disrupted	  estrous	  cyclicity	  in	  a	  rodent	  model	  [61].	  However,	  to	  
date	  no	  mutations	  in	  these	  upstream	  or	  regulatory	  factors	  have	  been	  reported	  in	  
patients	  with	  DP.	  
Epigenetic	  regulators	  are	  potential	  mediators	  of	  the	  effects	  of	  the	  environment	  
on	  the	  hypothalamic	  regulation	  of	  puberty.	  However,	  whilst	  experimental	  data	  
from	  rats	  gives	  evidence	  for	  changes	  in	  histone	  acetylation	  and	  gene	  methylation	  
leading	  to	  altered	  gene	  expression	  during	  puberty,	  the	  link	  between	  
environmental	  factors	  and	  epigenetic	  control	  of	  puberty	  via	  the	  hypothalamus	  
has	  not	  been	  established.	  Recent	  evidence	  highlights	  the	  importance	  in	  mice	  of	  
microRNAs	  (particularly	  the	  miR-­‐200/429	  family	  and	  miR-­‐155)	  in	  the	  epigenetic	  
upregulation	  of	  GnRH	  transcription	  during	  the	  critical	  period	  (murine	  equivalent	  
of	  the	  mini-­‐puberty)	  [62].	  Epigenetic	  changes	  during	  foetal	  life	  are	  also	  a	  
potential	  mechanism	  for	  the	  effects	  of	  EDCs	  in	  utero	  [63].	  
	  
Metabolism	  and	  timing	  of	  puberty	  
Nutritional	  changes	  play	  an	  important	  role	  in	  the	  observed	  secular	  trend	  
towards	  an	  earlier	  age	  of	  pubertal	  onset	  in	  the	  developed	  world	  [64],	  as	  shown	  
by	  the	  positive	  correlation	  between	  age	  at	  puberty	  onset	  and	  childhood	  body	  
size,	  particularly	  in	  girls	  [65].	  In	  contrast,	  under-­‐nutrition	  in	  females,	  for	  
example	  in	  chronic	  disease	  or	  anorexia	  nervosa,	  can	  result	  in	  delay	  in	  both	  the	  
onset	  and	  tempo	  of	  puberty.	  [66]	  
This	  relationship	  between	  fat	  mass	  and	  pubertal	  timing	  is	  mediated,	  at	  least	  in	  
part,	  through	  the	  permissive	  actions	  of	  the	  metabolic	  hormone	  leptin,	  a	  key	  
regulator	  of	  body	  mass,	  produced	  from	  white	  adipose	  tissue	  [67].	  Humans	  and	  
mice	  lacking	  leptin	  (Lep	  ob/ob)	  or	  the	  leptin	  receptor	  (LepR	  db/db)	  fail	  to	  
complete	  puberty	  and	  are	  infertile	  [68].	  GWAS	  studies	  of	  pubertal	  timing	  found,	  
in	  addition	  to	  leptin	  signaling,	  overlap	  with	  several	  genes	  implicated	  in	  body	  
mass	  index	  including	  FTO,	  SEC16B,	  TMEM18,	  and	  NEGR1	  [18].	  However,	  whilst	  
self-­‐limited	  DP	  in	  boys	  is	  associated	  with	  hypoleptinaemia	  [69],	  there	  have	  been	  
no	  identified	  association	  of	  specific	  leptin	  or	  leptin	  receptor	  polymorphisms	  with	  
DP	  [70].	  Ghrelin	  and	  other	  gut-­‐derived	  peptides	  may	  also	  form	  part	  of	  the	  
mechanism	  by	  which	  energy	  homeostasis	  regulates	  reproductive	  development	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[71].	  Notably,	  children	  with	  CDGP	  have	  a	  dual	  phenotype	  of	  slow	  growth	  in	  
childhood	  with	  DP.	  In	  contrast,	  both	  low	  birth	  weight	  and	  prematurity	  are	  
associated	  with	  earlier	  onset	  of	  puberty	  [72],	  particularly	  in	  those	  children	  with	  
rapid	  increase	  in	  length	  or	  weight	  in	  the	  first	  two	  years	  of	  life	  [73].	  It	  remains	  
unclear,	  however,	  if	  childhood	  obesity,	  insulin	  resistance,	  excess	  androgens	  or	  
underlying	  genetic	  or	  epigenetic	  factors	  may	  explain	  this	  association	  [74].	  
	  
Recent	  advances	  
Loss-­‐of-­‐function	  mutations	  in	  a	  member	  of	  the	  immunoglobulin	  superfamily,	  
IGSF1,	  have	  been	  identified	  in	  patients	  with	  X-­‐linked	  central	  hypothyroidism	  
[75].	  Notably,	  male	  patients	  with	  IGSF1	  mutations	  have	  a	  late	  increase	  in	  
testosterone	  levels	  with	  a	  delayed	  pubertal	  growth	  spurt.	  However,	  pathogenic	  
mutations	  in	  IGSF1	  have	  not	  been	  conclusively	  found	  in	  patients	  with	  isolated	  DP	  
[76].	  
More	  recently,	  whole	  exome	  and	  targeted	  resequencing	  methods	  have	  
implicated	  two	  pathogenic	  mutations	  in	  IGSF10	  as	  the	  causal	  factor	  for	  late	  
puberty	  in	  six	  unrelated	  families	  from	  a	  large	  Finnish	  cohort	  with	  familial	  DP	  
[77].	  A	  further	  two	  rare	  variants	  of	  unknown	  significance	  were	  identified	  in	  four	  
additional	  families	  from	  the	  cohort.	  Mutations	  in	  IGSF10	  appear	  to	  cause	  a	  
dysregulation	  of	  GnRH	  neuronal	  migration	  during	  embryonic	  development	  
(Figure	  3).	  An	  intact	  GnRH	  neurosecretory	  network	  is	  necessary	  for	  the	  correct	  
temporal	  pacing	  of	  puberty.	  Pathogenic	  IGSF10	  mutations	  leading	  to	  disrupted	  
IGSF10	  signaling	  potentially	  result	  in	  reduced	  numbers	  or	  mis-­‐timed	  arrival	  of	  
GnRH	  neurons	  at	  the	  hypothalamus;	  producing	  a	  functional	  defect	  in	  the	  GnRH	  
neuroendocrine	  network.	  With	  this	  impaired	  GnRH	  system	  there	  would	  follow	  
an	  increased	  ‘threshold’	  for	  the	  onset	  of	  puberty,	  with	  an	  ensuing	  delay	  in	  
pubertal	  timing.	  IGSF10	  loss-­‐of-­‐function	  mutations	  were	  also	  discovered	  in	  
patients	  with	  a	  hypothalamic	  amenorrhoea-­‐like	  phenotype.	  These	  findings	  
represent	  a	  new	  fetal	  origin	  of	  self-­‐limited	  DP,	  and	  reveal	  a	  potential	  shared	  
pathophysiology	  between	  DP	  and	  other	  forms	  of	  functional	  hypogonadism.	  
	  
Conclusions	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This	  review	  serves	  to	  highlight	  the	  fascinating	  heterogeneity	  of	  genetic	  defects	  
resulting	  in	  delayed	  and	  disordered	  puberty.	  Although	  our	  understanding	  of	  the	  
highly	  complex	  underlying	  biological	  network	  remains	  imperfect,	  results	  to	  date	  
demonstrate	  the	  importance	  of	  defects	  in	  GnRH	  neuronal	  development	  and	  
function,	  GnRH	  receptor	  and	  LH/FSH	  abnormalities,	  transcriptional	  regulation	  of	  
the	  HPG	  axis	  and	  metabolic	  and	  energy	  homeostasis	  derangements,	  in	  the	  
control	  of	  pubertal	  timing.	  
Clinically	  the	  distinction	  in	  adolescence	  between	  the	  conditions	  of	  DP	  and	  
congenital	  idiopathic	  HH	  is	  an	  important	  but	  difficult	  one.	  Both	  disorders	  can	  
present	  with	  a	  picture	  of	  functional	  hypogonadotropism	  and	  in	  some	  cases	  may	  
share	  an	  underlying	  pathophysiology.	  There	  remains	  no	  definitive	  test	  to	  
accurately	  discriminate	  between	  the	  two	  diagnoses.	  More	  complex	  and	  involved	  
management	  is	  required	  in	  patients	  with	  hypogonadism	  to	  achieve	  both	  
development	  of	  secondary	  sexual	  characteristics	  and	  to	  maximize	  the	  potential	  
for	  fertility	  [78].	  Rapid	  and	  efficient	  diagnosis	  of	  patients	  in	  clinic	  would	  
represent	  a	  huge	  leap	  forward	  in	  patient	  care	  and	  a	  likely	  significant	  economic	  
advantage.	  While	  presently	  next	  generation	  sequencing	  in	  individuals	  presenting	  
with	  delayed	  or	  incomplete	  pubertal	  development	  is	  only	  a	  reasonable	  option	  in	  
a	  research	  setting,	  future	  progress	  in	  gene	  discovery	  and	  technical	  developments	  
may	  facilitate	  the	  availability	  of	  genetic	  diagnosis	  as	  part	  of	  clinical	  care	  for	  
patients	  with	  both	  GnRH	  deficiency	  and	  self-­‐limiting	  DP.	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Figure	  1	  –	  The	  Genetics	  of	  Pubertal	  Timing.	  In	  the	  general	  population	  there	  is	  
a	  near-­‐normal	  distribution	  of	  the	  timing	  of	  pubertal	  onset,	  with	  the	  definitions	  of	  
precocious	  and	  delayed	  being	  statistically	  determined	  (+/-­‐	  2	  standard	  
deviations,	  SD).	  Strategies	  to	  determine	  key	  genetic	  determinants	  in	  the	  timing	  of	  
puberty	  include	  large	  genome	  wide	  association	  studies	  (GWAS)	  of	  age-­‐at-­‐
menarche	  and	  voice	  breaking	  in	  the	  general	  population,	  and	  identification	  of	  rare	  
high-­‐impact	  variants	  causing	  early,	  late	  or	  absent	  puberty	  in	  patients	  and	  their	  
families.	  G2	  –	  Tanner	  genital	  stage	  2	  in	  boys.	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Figure	  2	  –	  Overlap	  between	  genetic	  regulation	  in	  the	  general	  population	  
and	  extreme	  phenotypes.	  
Examples	  of	  genes	  implicated	  in	  timing	  of	  puberty	  from	  genome	  wide	  association	  
studies	  in	  the	  general	  population	  (GWAS),	  conditions	  of	  GnRH	  deficiency	  such	  as	  
idiopathic	  hypogonadotropic	  hypogonadism	  (IHH)	  and	  Kallmann	  Syndrome	  








Figure	  3	  –	  Schematic	  of	  the	  mechanism	  by	  which	  IGSF10	  mutations	  lead	  to	  
DP.	  Reduced	  levels	  of	  IGSF10	  expression	  during	  embryogenesis	  in	  the	  corridor	  of	  
nasal	  mesenchyme	  from	  the	  vomeronasal	  organ	  to	  the	  olfactory	  bulbs	  result	  in	  
delayed	  migration	  of	  GnRH	  neurons	  to	  the	  hypothalamus.	  This	  presents	  for	  the	  
first	  time	  in	  adolescence	  as	  a	  phenotype	  of	  DP	  due	  to	  abnormalities	  of	  the	  GnRH	  
neuronal	  network.	  
	  
